Cargando…
Imaging diagnosis of bronchogenic carcinoma (the forgotten disease) during times of COVID-19 pandemic: Current and future perspectives
Patients with bronchogenic carcinoma comprise a high-risk group for coronavirus disease 2019 (COVID-19), pneumonia and related complications. Symptoms of COVID-19 related pulmonary syndrome may be similar to deteriorating symptoms encountered during bronchogenic carcinoma progression. These resembla...
Autor principal: | Reddy, Ravikanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223714/ https://www.ncbi.nlm.nih.gov/pubmed/34189068 http://dx.doi.org/10.5306/wjco.v12.i6.437 |
Ejemplares similares
-
Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives
por: Feng, Bing, et al.
Publicado: (2021) -
Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023) -
Deep learning in hepatocellular carcinoma: Current status and future perspectives
por: Ahn, Joseph C, et al.
Publicado: (2021) -
Trends in Imaging Patterns of Bronchogenic Carcinoma: Reality or a Statistical Variation? A Single-Center Cross-Sectional Analysis of Outcomes
por: Reddy, Ravikanth, et al.
Publicado: (2022) -
Neisseria genomics: current status and future perspectives
por: Harrison, Odile B, et al.
Publicado: (2017)